Metabolism-Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy

dc.contributor.authorLiu, Chang
dc.contributor.organizationfi=teollisuusfysiikan laboratorio|en=Laboratory of Industrial Physics|
dc.contributor.organization-code1.2.246.10.2458963.20.66904373678
dc.converis.publication-id387055604
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/387055604
dc.date.accessioned2026-01-21T15:10:03Z
dc.date.available2026-01-21T15:10:03Z
dc.description.abstractNanocatalytic therapy, an emerging approach in cancer treatment, utilizes nanomaterials to initiate enzyme-mimetic catalytic reactions within tumors, inducing tumor-suppressive effects. However, the targeted and selective catalysis within tumor cells is challenging yet critical for minimizing the adverse effects. The distinctive reliance of tumor cells on glycolysis generates abundant lactate, influencing the tumor's pH, which can be manipulated to selectively activate nanozymatic catalysis. Herein, small interfering ribonucleic acid (siRNA) targeting lactate transporter-mediated efflux is encapsulated within the iron-based metal-organic framework (FeMOF) and specifically delivered to tumor cells through cell membrane coating. This approach traps lactate within the cell, swiftly acidifying the tumor cytoplasm and creating an environment for boosting the catalysis of the FeMOF nanozyme. The nanozyme generates hydroxyl radical (center dot OH) in the reversed acidic environment, using endogenous hydrogen peroxide (H2O2) produced by mitochondria as a substrate. The induced cytoplasmic acidification disrupts calcium homeostasis, leading to mitochondrial calcium overload, resulting in mitochondrial dysfunction and subsequent tumor cell death. Additionally, the tumor microenvironment is also remodeled, inhibiting migration and invasion, thus preventing metastasis. This groundbreaking strategy combines metabolic regulation with nanozyme catalysis in a toxic drug-free approach for tumor treatment, holding promise for future clinical applications.Emerging nanocatalytic therapies utilize nanomaterials to induce tumor inhibition through enzyme-like reactions. Lactate-targeted siRNAs in FeMOF can be selectively delivered to tumor cells, triggering intracellular acidification, enhancing the catalytic effect of the nano-enzymes, generating hydroxyl radicals and calcium influx, and disrupting mitochondrial function to eliminate tumors, while simultaneously remodeling the tumor microenvironment to inhibit tumor migration and metastasis.image
dc.identifier.eissn1613-6829
dc.identifier.jour-issn1613-6810
dc.identifier.olddbid214163
dc.identifier.oldhandle10024/197181
dc.identifier.urihttps://www.utupub.fi/handle/11111/56422
dc.identifier.urlhttps://doi.org/10.1002/smll.202307794
dc.identifier.urnURN:NBN:fi-fe2025082792882
dc.language.isoen
dc.okm.affiliatedauthorMäkilä, Ermei
dc.okm.affiliatedauthorZhang, Hongbo
dc.okm.discipline317 Pharmacyen_GB
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWILEY-V C H VERLAG GMBH
dc.publisher.countryGermanyen_GB
dc.publisher.countrySaksafi_FI
dc.publisher.country-codeDE
dc.publisher.placeWEINHEIM
dc.relation.articlenumber2307794
dc.relation.doi10.1002/smll.202307794
dc.relation.ispartofjournalSmall
dc.relation.issue24
dc.relation.volume20
dc.source.identifierhttps://www.utupub.fi/handle/10024/197181
dc.titleMetabolism-Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy
dc.year.issued2024

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Small - 2024 - Liu - Metabolism‐Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy.pdf
Size:
5.22 MB
Format:
Adobe Portable Document Format